Trade Summary

3 days ago, RA CAPITAL MANAGEMENT, L.P., serving as Dir at Artiva Biotherapeutics, Inc. (ARTV), purchased 1,027,722 shares at $7.44 per share, for a total transaction value of $7,650,148.29. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 16,231,717 shares of ARTV.

This purchase represents a 6.76% increase in RA CAPITAL MANAGEMENT, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 at 7:36 PM ET, 2 days after the trade was made.

Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.